What is a normal homocysteine level?
Updated October 31, 2026 · 16 sources · Written by the AumniVIDA team
UnitsShort answer
A normal homocysteine level in adults is about 5 to 15 µmol/L, with lab upper limits that rise with age, from 14.5 at 18 to 60 years to 21.3 after 80 at one large US lab. Prevention researchers consider 10 µmol/L or below probably safe. There is no agreed lower limit.
Upper reference limit by age at one large US lab
- Age 2 to 129 µmol/L
- Age 13 to 1711 µmol/L
- Age 18 to 6014.5 µmol/L
- Age 61 to 7017.2 µmol/L
- Age 71 to 8019.2 µmol/L
- Over 8021.3 µmol/L
Show the data
| Item | Value (µmol/L) | Low | High | Note |
|---|---|---|---|---|
| Age 2 to 12 | 9 | |||
| Age 13 to 17 | 11 | |||
| Age 18 to 60 | 14.5 | |||
| Age 61 to 70 | 17.2 | |||
| Age 71 to 80 | 19.2 | |||
| Over 80 | 21.3 |
Key takeaways
- 1
Typical adult range is 5 to 15 µmol/L; above 15 is hyperhomocysteinemia [1].
- 2
Lab upper limits rise with age: Labcorp uses 14.5 µmol/L at 18 to 60 and 21.3 over 80 [2].
- 3
Prevention researchers set the bar lower: 10 or below probably safe, 11 or above worth acting on [3].
- 4
Men run about 1 to 2 µmol/L higher than women of the same age [4].
- 5
There is no accepted lower limit; one cohort linked values of 8.9 or below to more dementia [5].
What is a normal homocysteine level?
For most adults, 5 to 15 µmol/L. Each lab sets its own interval, and many raise the upper limit with age.
Clinical references give a typical range of 5 to 15 µmol/L and define hyperhomocysteinemia as above 15 µmol/L [1]. ARUP reports an adult reference interval of 0 to 15 µmol/L [6]. Labcorp uses age bands, shown in the chart [2].
Lab intervals describe where most tested people fall, not what is optimal. They come from local populations, and populations eating folic-acid-fortified food run lower: after US fortification, mean homocysteine fell from 10.1 to 9.4 µmol/L [7].
Always compare your result with the range printed on your own report, and with your own earlier results measured the same way.
Upper reference limit by age at one large US lab
- Age 2 to 129 µmol/L
- Age 13 to 1711 µmol/L
- Age 18 to 6014.5 µmol/L
- Age 61 to 7017.2 µmol/L
- Age 71 to 8019.2 µmol/L
- Over 8021.3 µmol/L
Show the data
| Item | Value (µmol/L) | Low | High | Note |
|---|---|---|---|---|
| Age 2 to 12 | 9 | |||
| Age 13 to 17 | 11 | |||
| Age 18 to 60 | 14.5 | |||
| Age 61 to 70 | 17.2 | |||
| Age 71 to 80 | 19.2 | |||
| Over 80 | 21.3 |
What is an ideal or optimal homocysteine level?
There is no official optimal level. Prevention researchers suggest 10 µmol/L or below as probably safe, and trials found brain benefits mainly above 11 to 13 µmol/L.
The most specific proposal comes from Smith and Refsum, who reviewed more than 100 conditions linked to homocysteine and concluded that adult values of 10 µmol/L or below are probably safe and 11 µmol/L or above may justify intervention [3]. The dementia consensus describes values above 11 µmol/L as moderately raised in older people [8].
Trial data support thresholds in this region for brain outcomes. In VITACOG, the B-vitamin benefit on brain atrophy was confined to people above the median of 11 µmol/L [9] and reached 53% above 13 µmol/L [10].
For heart attacks, there is no evidence that pushing homocysteine lower helps: trials that cut it by 25% did not reduce heart attacks [11]. A "good homocysteine number" therefore depends on the question. For brain health in older adults, under about 10 to 11 is the researchers' target. For cardiovascular risk, other markers, such as ApoB, carry more weight.
| Threshold | Who uses it | Basis |
|---|---|---|
| 10 or below | Smith and Refsum 2021 | Probably safe in adults |
| Above 11 | Dementia consensus 2018; VITACOG | Moderately raised; brain benefit above median of 11 |
| Above 13 | VITACOG 2010; fortification study 1999 | 53% slower brain atrophy with B vitamins; defined as high |
| Above 14 | Framingham 2002 | Alzheimer risk nearly doubled |
| 14.5 to 21.3 by age | Labcorp | Upper reference limit from age 18 to over 80 |
| Above 15 | ARUP; StatPearls | Upper reference limit; hyperhomocysteinemia |
What are normal homocysteine levels by age and sex?
Homocysteine rises with age and is higher in men. In Norwegian adults, average levels were 10.8 in men and 9.1 in women at 40 to 42 years, and 12.3 and 11.0 at 65 to 67.
The Hordaland Homocysteine Study measured 16,176 Norwegian adults aged 40 to 67 [4]:
| Age | Men, geometric mean | Women, geometric mean |
|---|---|---|
| 40 to 42 years | 10.8 µmol/L | 9.1 µmol/L |
| 65 to 67 years | 12.3 µmol/L | 11.0 µmol/L |
Age and kidney function, measured as creatinine, are both independent determinants of homocysteine [12]. Lab ranges follow the same pattern. Labcorp's upper limits, the same for men and women, run from 9.0 µmol/L at 2 to 12 years to 14.5 at 18 to 60, 17.2 at 61 to 70, 19.2 at 71 to 80 and 21.3 over 80 [2].
Women. Folic acid lowers homocysteine more in women than in men [13]. Most labs do not publish a separate female range; ask your lab whether yours does.
Men. Men had higher levels than women at every age in the Hordaland data, and smoking widened the gap [4].
What is considered low homocysteine?
There is no agreed definition of low homocysteine. Labs report from 0 upward, values below about 5 µmol/L are uncommon, and low results often reflect high-dose vitamin use.
Reference intervals start at 0 µmol/L at Labcorp and ARUP [2][6], so a low result is not flagged as abnormal. The typical adult range starts at about 5 µmol/L [1].
The few studies of low values are observational:
- In 2,655 Korean adults over 60, people at 8.9 µmol/L or below had 4 to 5 times the dementia risk of those at 9.0 to 10.5, similar to people at 10.6 or above, and 41.2% of the low group took vitamin supplements [5].
- In a retrospective review of 37,442 clinic patients, very low homocysteine was uncommon but linked to idiopathic peripheral neuropathy [14].
These studies cannot show that low homocysteine causes harm. They do suggest that pushing values ever lower with high-dose supplements has no proven benefit. The Hordaland data found low homocysteine associated with better physical and mental health overall [12].
Can homocysteine be too low?
Possibly, but the evidence is thin. Homocysteine feeds the pathway to cysteine and glutathione, and two observational studies link very low values to dementia or neuropathy.
Homocysteine is not a waste product. It is the step between methionine and cysteine, which the body uses for glutathione and taurine [1]. In theory, very low homocysteine could reflect a pathway running in an unusual way.
In practice, data are limited to the observational studies above [5][14]. No trial has tested raising homocysteine. If your result is low and you take high-dose B vitamins or methyl donors, the simplest question for your clinician is whether you still need that dose. Searches for "how to increase homocysteine naturally" rarely have a medical answer beyond reviewing supplements.
How do you convert homocysteine units?
Homocysteine is reported in µmol/L almost everywhere. To convert from mg/L, multiply by about 7.4.
Homocysteine has a molar mass of about 135 g/mol, so 1 mg/L equals about 7.4 µmol/L. Published papers show the pairing: 3 µmol/L is 0.41 mg/L [15] and 2.4 µmol/L is 0.3 mg/L [16].
- 10 µmol/L is about 1.35 mg/L
- 15 µmol/L is about 2.0 mg/L
- 30 µmol/L is about 4.1 mg/L
Some reports write µmol/L as umol/L or micromol/L; they are the same unit. See what high homocysteine means if your value is above the range.
More about Homocysteine
- Homocysteine: the full guideHomocysteine is an amino acid your body makes when it uses methionine from protein.
- Homocysteine test: why it is done and how to prepareA homocysteine test measures total homocysteine in plasma, in µmol/L.
- How to lower homocysteineFolic acid is the strongest lever: 0.4 mg a day lowers homocysteine by about 20% and 0.8 mg by about 23%.
- What does high homocysteine mean?High homocysteine, above about 15 µmol/L, usually means a folate or B12 shortfall, reduced kidney function, hypothyroidism, a drug effect or the MTHFR TT genotype with low folate.
- Homocysteine, B12 and MTHFRVitamin B12 and folate recycle homocysteine, so low B12 raises homocysteine and methylmalonic acid, while low folate raises homocysteine only.
Protocols that act on Homocysteine
- Plant-based and vegan dietsA plant-based diet gets most or all of its food from plants: vegan diets exclude all animal foods, vegetarian diets exclude meat and fish.
- Mediterranean dietThe Mediterranean diet is an eating pattern built on vegetables, fruit, legumes, whole grains, nuts, fish and olive oil as the main fat, with little red or processed meat, butter or sweets.
- MIND dietThe MIND diet (Mediterranean-DASH Intervention for Neurodegenerative Delay) is a brain-focused hybrid of the Mediterranean and DASH diets that scores 15 food groups: more leafy greens, berries, nuts, beans, whole grains, fish and olive oil, and less red meat, butter, cheese, sweets and fried food.
Common questions
What is the normal homocysteine range for females?
What is the normal homocysteine range for males?
The same lab range applies; average levels were 10.8 µmol/L at 40 to 42 and 12.3 at 65 to 67 in Norwegian men [4].
What is a good homocysteine number?
Under 15 µmol/L is within lab ranges; prevention researchers consider 10 or below probably safe [3].
What are optimal homocysteine levels?
No guideline defines one. Smith and Refsum suggest 10 µmol/L or below [3].
Sources
- 1.Son P, Lewis L. Hyperhomocysteinemia. StatPearls, 2022. PubMed 32119295
- 2.Labcorp. Homocyst(e)ine, Plasma (test 706994). Labcorp test menu, 2026. Link
- 3.Smith AD, Refsum H. Homocysteine - from disease biomarker to disease prevention. J Intern Med, 2021. doi:10.1111/joim.13279
- 4.Nygård O, Vollset SE, Refsum H, et al. Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA, 1995. doi:10.1001/jama.1995.03530190040032
- 5.Bae JB, Han JW, Song J, et al. Hypohomocysteinemia may increases the risk of dementia and Alzheimer's disease: A nationwide population-based prospective cohort study. Clin Nutr, 2021. doi:10.1016/j.clnu.2021.05.034
- 6.ARUP Laboratories. Homocysteine, Total (test 0099869). ARUP Laboratory Test Directory, 2026. Link
- 7.Jacques PF, Selhub J, Bostom AG, et al. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med, 1999. doi:10.1056/NEJM199905133401901
- 8.Smith AD, Refsum H, Bottiglieri T, et al. Homocysteine and Dementia: An International Consensus Statement. J Alzheimers Dis, 2018. doi:10.3233/JAD-171042
- 9.Douaud G, Refsum H, de Jager CA, et al. Preventing Alzheimer's disease-related gray matter atrophy by B-vitamin treatment. Proc Natl Acad Sci U S A, 2013. doi:10.1073/pnas.1301816110
- 10.Smith AD, Smith SM, de Jager CA, et al. Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLoS One, 2010. doi:10.1371/journal.pone.0012244
- 11.Clarke R, Halsey J, Lewington S, et al. Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals. Arch Intern Med, 2010. doi:10.1001/archinternmed.2010.348
- 12.Refsum H, Nurk E, Smith AD, et al. The Hordaland Homocysteine Study: a community-based study of homocysteine, its determinants, and associations with disease. J Nutr, 2006. doi:10.1093/jn/136.6.1731S
- 13.Homocysteine Lowering Trialists' Collaboration. Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials. Am J Clin Nutr, 2005. doi:10.1093/ajcn/82.4.806
- 14.Cullen CE, Carter GT, Weiss MD, et al. Hypohomocysteinemia: a potentially treatable cause of peripheral neuropathology?. Phys Med Rehabil Clin N Am, 2012. doi:10.1016/j.pmr.2011.11.001
- 15.Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA, 2002. doi:10.1001/jama.288.16.2015
- 16.Lonn E, Yusuf S, Arnold MJ, et al. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med, 2006. doi:10.1056/NEJMoa060900